Fennec Pharmaceuticals Inc. (FENC) Dividend History

Fennec Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative treatments for rare and life-threatening pediatric diseases. The company's lead candidate, seek to address unmet medical needs by advancing therapies that improve patient outcomes in areas such as oncology and pain management.

Po Box 13628, Research Triangle Park, NC, 27709
Phone: (919) 636-4530
Website: https://www.fennecpharma.com

Dividend History

Fennec Pharmaceuticals Inc. currently does not pay dividends

Company News

  • Fennec Pharmaceuticals reported strong first-quarter 2025 financial results, with total net revenues up 18% year-over-year. The company attributed the positive momentum to its refined sales strategy and enhanced patient support services.

    GlobeNewswire Inc.
  • Adherex Technologies (FENC) delivered earnings and revenue surprises of -16.33% and 142.70%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

    Zacks Investment Research
    Featured Companies: GANX
  • Analysts have provided the following ratings for Fennec Pharmaceuticals (NASDAQ:FENC) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 3 1 0 0 0 Last 30D 1 0 0 0 0 1M Ago 0 0 0 0 0 2M Ago 0 0 0 0 0 3M Ago 2 1 0 0 0 According to 4 analyst offering 12-month price targets in the last 3 months, Fennec Pharmaceuticals has an average price target of $17.5 with a high of $18.00 and a low of $16.00. Below is a summary of how these 4 analysts rated Fennec Pharmaceuticals over the past 3 months. The greater the number of bullish ...Full story available on Benzinga.com

    Benzinga
  • Listen on the go! A daily podcast of Wall Street Breakfast's Alpha Talks will be available this morning on Seeking Alpha, iTunes, Stitcher and Spotify.

    Seeking Alpha
Page data last updated 07/23/2025 16:25:44 UTC